BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 27209485)

  • 1. Synthesis and evaluation of (18)F-labeled 5-HT2A receptor agonists as PET ligands.
    Herth MM; Petersen IN; Hansen HD; Hansen M; Ettrup A; Jensen AA; Lehel S; Dyssegaard A; Gillings N; Knudsen GM; Kristensen JL
    Nucl Med Biol; 2016 Aug; 43(8):455-62. PubMed ID: 27209485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiosynthesis and evaluation of 11C-CIMBI-5 as a 5-HT2A receptor agonist radioligand for PET.
    Ettrup A; Palner M; Gillings N; Santini MA; Hansen M; Kornum BR; Rasmussen LK; Någren K; Madsen J; Begtrup M; Knudsen GM
    J Nucl Med; 2010 Nov; 51(11):1763-70. PubMed ID: 20956470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiosynthesis and in vivo evaluation of a series of substituted 11C-phenethylamines as 5-HT (2A) agonist PET tracers.
    Ettrup A; Hansen M; Santini MA; Paine J; Gillings N; Palner M; Lehel S; Herth MM; Madsen J; Kristensen J; Begtrup M; Knudsen GM
    Eur J Nucl Med Mol Imaging; 2011 Apr; 38(4):681-93. PubMed ID: 21174090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Convergent
    Petersen IN; Villadsen J; Hansen HD; Jensen AA; Lehel S; Gillings N; Herth MM; Knudsen GM; Kristensen JL
    Bioorg Med Chem; 2016 Nov; 24(21):5353-5356. PubMed ID: 27624522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serotonin 2A receptor agonist binding in the human brain with [(11)C]Cimbi-36: Test-retest reproducibility and head-to-head comparison with the antagonist [(18)F]altanserin.
    Ettrup A; Svarer C; McMahon B; da Cunha-Bang S; Lehel S; Møller K; Dyssegaard A; Ganz M; Beliveau V; Jørgensen LM; Gillings N; Knudsen GM
    Neuroimage; 2016 Apr; 130():167-174. PubMed ID: 26876490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, radiofluorination, and preliminary evaluation of the potential 5-HT
    Edgar FG; Hansen HD; Leth-Petersen S; Ettrup A; Kristensen JL; Knudsen GM; Herth MM
    J Labelled Comp Radiopharm; 2017 Oct; 60(12):586-591. PubMed ID: 28856700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of [(11)C]Cimbi-36 as an agonist PET radioligand for the 5-HT(2A) and 5-HT(2C) receptors in the nonhuman primate brain.
    Finnema SJ; Stepanov V; Ettrup A; Nakao R; Amini N; Svedberg M; Lehmann C; Hansen M; Knudsen GM; Halldin C
    Neuroimage; 2014 Jan; 84():342-53. PubMed ID: 23994452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebral 5-HT release correlates with [
    Jørgensen LM; Weikop P; Villadsen J; Visnapuu T; Ettrup A; Hansen HD; Baandrup AO; Andersen FL; Bjarkam CR; Thomsen C; Jespersen B; Knudsen GM
    J Cereb Blood Flow Metab; 2017 Feb; 37(2):425-434. PubMed ID: 26825776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preclinical safety assessment of the 5-HT2A receptor agonist PET radioligand [ 11C]Cimbi-36.
    Ettrup A; Holm S; Hansen M; Wasim M; Santini MA; Palner M; Madsen J; Svarer C; Kristensen JL; Knudsen GM
    Mol Imaging Biol; 2013 Aug; 15(4):376-83. PubMed ID: 23306971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serotonin 2A receptor agonist binding in the human brain with [¹¹C]Cimbi-36.
    Ettrup A; da Cunha-Bang S; McMahon B; Lehel S; Dyssegaard A; Skibsted AW; Jørgensen LM; Hansen M; Baandrup AO; Bache S; Svarer C; Kristensen JL; Gillings N; Madsen J; Knudsen GM
    J Cereb Blood Flow Metab; 2014 Jul; 34(7):1188-96. PubMed ID: 24780897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and in vitro evaluation of [18F]FECIMBI-36: A potential agonist PET ligand for 5-HT2A/2C receptors.
    Prabhakaran J; Underwood MD; Kumar JS; Simpson NR; Kassir SA; Bakalian MJ; Mann JJ; Arango V
    Bioorg Med Chem Lett; 2015 Sep; 25(18):3933-6. PubMed ID: 26253634
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Petersen IN; Villadsen J; Hansen HD; Madsen J; Jensen AA; Gillings N; Lehel S; Herth MM; Knudsen GM; Kristensen JL
    Org Biomol Chem; 2017 May; 15(20):4351-4358. PubMed ID: 28474719
    [No Abstract]   [Full Text] [Related]  

  • 13. (11)C-labeling and preliminary evaluation of pimavanserin as a 5-HT2A receptor PET-radioligand.
    Andersen VL; Hansen HD; Herth MM; Dyssegaard A; Knudsen GM; Kristensen JL
    Bioorg Med Chem Lett; 2015 Mar; 25(5):1053-6. PubMed ID: 25655720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Common HTR2A variants and 5-HTTLPR are not associated with human in vivo serotonin 2A receptor levels.
    Spies M; Nasser A; Ozenne B; Jensen PS; Knudsen GM; Fisher PM
    Hum Brain Mapp; 2020 Nov; 41(16):4518-4528. PubMed ID: 32697408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The importance of small polar radiometabolites in molecular neuroimaging: A PET study with [
    Johansen A; Hansen HD; Svarer C; Lehel S; Leth-Petersen S; Kristensen JL; Gillings N; Knudsen GM
    J Cereb Blood Flow Metab; 2018 Apr; 38(4):659-668. PubMed ID: 29215308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo evaluation of [
    Prabhakaran J; Solingapuram Sai KK; Zanderigo F; Rubin-Falcone H; Jorgensen MJ; Kaplan JR; Tooke KI; Mintz A; Mann JJ; Kumar JSD
    Bioorg Med Chem Lett; 2017 Jan; 27(1):21-23. PubMed ID: 27889455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and evaluation in rats of the dopamine D2/3 receptor agonist 18F-AMC20 as a potential radioligand for PET.
    Shalgunov V; van Wieringen JP; Janssen HM; Fransen PM; Dierckx RA; Michel MC; Booij J; Elsinga PH
    J Nucl Med; 2015 Jan; 56(1):133-9. PubMed ID: 25476538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The selective 5-HT
    Jensen AA; Halberstadt AL; Märcher-Rørsted E; Odland AU; Chatha M; Speth N; Liebscher G; Hansen M; Bräuner-Osborne H; Palner M; Andreasen JT; Kristensen JL
    Biochem Pharmacol; 2020 Jul; 177():113979. PubMed ID: 32298690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiosynthesis and in vivo evaluation of novel radioligands for PET imaging of cerebral 5-HT7 receptors.
    Hansen HD; Herth MM; Ettrup A; Andersen VL; Lehel S; Dyssegaard A; Kristensen JL; Knudsen GM
    J Nucl Med; 2014 Apr; 55(4):640-6. PubMed ID: 24566002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levels.
    Madsen MK; Fisher PM; Burmester D; Dyssegaard A; Stenbæk DS; Kristiansen S; Johansen SS; Lehel S; Linnet K; Svarer C; Erritzoe D; Ozenne B; Knudsen GM
    Neuropsychopharmacology; 2019 Jun; 44(7):1328-1334. PubMed ID: 30685771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.